[1] OSMAN A.MicroRNAs in health and disease——basic science and clinical applications[J].Clin Lab,2012,58(5/6):393.
[2] CHO WC.MicroRNAs:potential biomarkers for cancer diagnosis,prognosis and targets for therapy[J].Int J Biochem Cell Biol,2010,42(8):1273.
[3] ZENG Q,JIN C,CHEN W,et al.Downregulation of serum miR-17 and miR-106b levels in gastric cancer and benign gastric diseases[J].Chin J Cancer Res,2014,26(6):711.
[4] TAN W,LI Y,LIM SG,et al.miR-106b-25/miR-17-92 clusters:polycistrons with oncogenic roles in hepatocellular carcinoma[J].World J Gastroenterol,2014,20(20):5962.
[5] NI X,XIA T,ZHAO Y,et al.Downregulation of miR-106b induced breast cancer cell invasion and motility in association with overexpression of matrix metalloproteinase 2[J].Cancer Sci,2014,105(1):18.
[6] ZHANG A,HAO J,WANG K,et al.Down-regulation of miR-106b suppresses the growth of human glioma cells[J].J Neurooncol,2013,112(2):179.
[7] CAI K,WANG Y,BAO X.MiR-106b promotes cell proliferation via targeting RB in laryngeal carcinoma[J].J Exp Clin Cancer Res,2011,30:73.
[8] YAO YL,WU XY,WU JH,et al.Effects of microRNA-106 on proliferation of gastric cancer cell through regulating p21 and E2F5[J].Asian Pac J Cancer Prev,2013,14(5):2839.
[9] YANG TS,YANG XH,CHEN X,et al.MicroRNA-106b in cancer-associated fibroblasts from gastric cancer promotes cell migration and invasion by targeting PTEN[J].FEBS Lett,2014,588(13):2162.
[10] TORRE LA,BRAY F,SIEGEL RL,et al.Global cancer statistics,2012[J].CA Cancer J Clin,2015,65(2):87.
[11] SCHEFLER AC,CICCIARELLI N,FEUER W,et al.Macular retinoblastoma:evaluation of tumor control,local complications,and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation[J].Ophthalmology,2007,114(1):162.
[12] YATES LA,NORBURY CJ,GILBERT RJ.The long and short of microRNA[J].Cell,2013,153(3):516.